Cargando…

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

Detalles Bibliográficos
Autores principales:	Bøtker, Hans Erik, Hausenloy, Derek, Andreadou, Ioanna, Antonucci, Salvatore, Boengler, Kerstin, Davidson, Sean M., Deshwal, Soni, Devaux, Yvan, Di Lisa, Fabio, Di Sante, Moises, Efentakis, Panagiotis, Femminò, Saveria, García-Dorado, David, Giricz, Zoltán, Ibanez, Borja, Iliodromitis, Efstathios, Kaludercic, Nina, Kleinbongard, Petra, Neuhäuser, Markus, Ovize, Michel, Pagliaro, Pasquale, Rahbek-Schmidt, Michael, Ruiz-Meana, Marisol, Schlüter, Klaus-Dieter, Schulz, Rainer, Skyschally, Andreas, Wilder, Catherine, Yellon, Derek M., Ferdinandy, Peter, Heusch, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Practical Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105267/ https://www.ncbi.nlm.nih.gov/pubmed/30120595 http://dx.doi.org/10.1007/s00395-018-0696-8

Ejemplares similares

Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
por: Kleinbongard, Petra, et al.
Publicado: (2020)

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
por: Lecour, Sandrine, et al.
Publicado: (2021)

Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost
por: Efentakis, Panagiotis, et al.
Publicado: (2022)

ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
por: Lecour, Sandrine, et al.
Publicado: (2014)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
por: Hausenloy, Derek J., et al.
Publicado: (2017)

Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function
por: Comità, Stefano, et al.
Publicado: (2021)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Larger infarct size but equal protection by ischemic conditioning in septum and anterior free wall of pigs with LAD occlusion
por: Skyschally, Andreas, et al.
Publicado: (2019)

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
por: Kleinbongard, Petra, et al.
Publicado: (2023)

No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult Göttingen minipigs
por: Kleinbongard, Petra, et al.
Publicado: (2023)

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
por: Hausenloy, Derek J., et al.
Publicado: (2016)

The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury
por: Jensen, Rebekka Vibjerg, et al.
Publicado: (2019)

Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
por: Heusch, Gerd, et al.
Publicado: (2023)

Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction
por: Bøtker, Hans Erik, et al.
Publicado: (2020)

Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop
por: Pickard, Jack M. J., et al.
Publicado: (2014)

Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning
por: Gedik, Nilguen, et al.
Publicado: (2016)

Monoamine oxidase A-dependent ROS formation modulates human cardiomyocyte differentiation through AKT and WNT activation
por: Di Sante, Moises, et al.
Publicado: (2023)

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
por: Hausenloy, Derek J., et al.
Publicado: (2010)

Mitochondria in Cardiac Postconditioning
por: Pagliaro, Pasquale, et al.
Publicado: (2018)

Reactive oxygen species and redox compartmentalization
por: Kaludercic, Nina, et al.
Publicado: (2014)

Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes
por: Deshwal, Soni, et al.
Publicado: (2018)

Redox Aspects of Chaperones in Cardiac Function
por: Penna, Claudia, et al.
Publicado: (2018)

Non-responsiveness to cardioprotection by ischaemic preconditioning in Ossabaw minipigs with genetic predisposition to, but without the phenotype of the metabolic syndrome
por: Kleinbongard, Petra, et al.
Publicado: (2022)

Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology
por: Davidson, Sean M., et al.
Publicado: (2018)

Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor
por: Lieder, Helmut Raphael, et al.
Publicado: (2022)

Reciprocal regulation of eNOS, H(2)S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin
por: Sigala, Fragiska, et al.
Publicado: (2017)

Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients?: Editorial to “Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins Against Ischemia–reperfusion Injury in the Rat” by Ye et al.
por: Riksen, Niels P., et al.
Publicado: (2008)

Reduction of Myocardial Infarct Size by Dronedarone in Pigs—A Pleiotropic Action?
por: Skyschally, Andreas, et al.
Publicado: (2011)

Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor
por: Penna, Claudia, et al.
Publicado: (2021)

Ischaemic Preconditioning and Postconditioning do not Affect Adenosine A(1) and A(2A) Receptor Sensitivity
por: Riksen, Niels P., et al.
Publicado: (2009)

Preconditioning the diabetic human myocardium
por: Sivaraman, Vivek, et al.
Publicado: (2010)

A TRICk to Improve the Effectiveness of RIC: Role of Limb Temperature in Enhancing the Effectiveness of Remote Ischemic Conditioning
por: Penna, Claudia, et al.
Publicado: (2022)

Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis
por: Antonucci, Salvatore, et al.
Publicado: (2019)

Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop
por: Bell, R. M., et al.
Publicado: (2022)

Effect of Remote Ischemic Preconditioning on Acute Kidney Injury in Nondiabetic Patients Undergoing Coronary Artery Bypass Graft Surgery: A Secondary Analysis of 2 Small Randomized Trials
por: Venugopal, Vinod, et al.
Publicado: (2010)

Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs
por: Skyschally, Andreas, et al.
Publicado: (2010)

Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration
por: Gedik, Nilguen, et al.
Publicado: (2013)

Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning
por: Pickard, Jack M. J., et al.
Publicado: (2016)

Proteomics/phosphoproteomics of left ventricular biopsies from patients with surgical coronary revascularization and pigs with coronary occlusion/reperfusion: remote ischemic preconditioning
por: Gedik, Nilgün, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8qjcavi1f93jv5gjgeocolfges